Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 3.357
AS - Asia 1.918
EU - Europa 1.602
SA - Sud America 392
Continente sconosciuto - Info sul continente non disponibili 136
AF - Africa 69
OC - Oceania 13
Totale 7.487
Nazione #
US - Stati Uniti d'America 3.211
SG - Singapore 939
SE - Svezia 429
CN - Cina 374
BR - Brasile 320
IT - Italia 320
DE - Germania 186
VN - Vietnam 166
FR - Francia 160
GB - Regno Unito 109
IE - Irlanda 100
IN - India 77
RU - Federazione Russa 72
BD - Bangladesh 59
JP - Giappone 58
CA - Canada 56
ID - Indonesia 55
FI - Finlandia 47
HK - Hong Kong 35
MX - Messico 32
PL - Polonia 25
AR - Argentina 22
NL - Olanda 22
ES - Italia 21
TR - Turchia 19
UA - Ucraina 19
ZA - Sudafrica 19
BE - Belgio 18
IQ - Iraq 17
KR - Corea 16
CO - Colombia 14
SC - Seychelles 14
IL - Israele 12
EC - Ecuador 11
MA - Marocco 11
PH - Filippine 11
CR - Costa Rica 10
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
AT - Austria 9
CZ - Repubblica Ceca 9
MY - Malesia 9
DK - Danimarca 8
HN - Honduras 8
IR - Iran 8
JM - Giamaica 8
PR - Porto Rico 8
SA - Arabia Saudita 8
CH - Svizzera 7
CI - Costa d'Avorio 7
LT - Lituania 7
NZ - Nuova Zelanda 7
VE - Venezuela 7
AU - Australia 6
BY - Bielorussia 6
CL - Cile 6
GR - Grecia 6
NI - Nicaragua 6
PT - Portogallo 6
UZ - Uzbekistan 5
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
GT - Guatemala 4
GY - Guiana 4
JO - Giordania 4
KE - Kenya 4
LB - Libano 4
PY - Paraguay 4
TN - Tunisia 4
CW - ???statistics.table.value.countryCode.CW??? 3
HU - Ungheria 3
KZ - Kazakistan 3
RO - Romania 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
GP - Guadalupe 2
MM - Myanmar 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 7.346
Città #
Singapore 569
Ashburn 393
Chandler 383
San Jose 274
New York 137
Dublin 99
Beijing 97
Dallas 93
Council Bluffs 89
Los Angeles 79
Rome 78
Frankfurt am Main 57
Tokyo 55
Lauterbourg 52
Ho Chi Minh City 51
Jakarta 50
San Mateo 49
The Dalles 49
North Bergen 47
Boston 40
Munich 40
Helsinki 37
São Paulo 37
Hanoi 36
Princeton 35
Moscow 34
Hefei 33
Hong Kong 32
Marseille 32
Milan 31
Wilmington 30
Chicago 29
Santa Clara 28
Orem 26
Jacksonville 23
Fairfield 22
Houston 22
Cattolica 20
Boardman 19
Denver 19
Nanjing 19
Da Nang 18
Phoenix 18
San Francisco 17
Atlanta 16
Chennai 16
Warsaw 16
Montreal 15
Redwood City 15
Bologna 14
Bremen 14
Buffalo 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Johannesburg 14
London 14
Seattle 14
Toronto 14
Brussels 13
Poplar 13
Stockholm 13
Brooklyn 12
Edinburgh 12
Mexico City 12
Norwalk 12
Seoul 12
Hyderabad 11
Nuremberg 11
Kent 10
Paris 10
Amsterdam 9
Bexley 9
Hebei 9
Manchester 9
Woodbridge 9
Agrolândia 8
Newark 8
Querétaro 8
Rio de Janeiro 8
Shenyang 8
Abidjan 7
Ann Arbor 7
Augusta 7
Baghdad 7
Charlotte 7
Dhaka 7
Falkenstein 7
Guangzhou 7
Auckland 6
Brno 6
Florence 6
Las Vegas 6
Memphis 6
Minsk 6
New Delhi 6
Roubaix 6
San Diego 6
Shanghai 6
Tukwila 6
Totale 3.964
Nome #
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 213
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 200
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 196
Immunological role of IgG subclasses 191
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 191
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 190
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 181
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 175
Evaluation of screening method for Bence Jones protein analysis 170
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 169
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 162
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 161
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 160
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 159
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 159
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 155
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 154
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 154
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 151
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 151
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 150
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 148
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 148
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 148
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 147
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 147
Immunological role of IgG subclasses 145
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 143
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 141
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 141
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 140
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 139
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 137
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 134
The Laboratory Role in anti-TNF Biological Therapy Era 133
The dark side of current analytic methods for Bence Jones Proteinuria 128
Serum free light chain quantitative assays: Dilemma of a biomarker 126
Heavy chain disease: Our experience 123
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 122
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 121
Free light chains and autoimmunity 120
IgG cryoglobulinemia 119
Cryoglobulins: putative effectors of adaptive immune response 117
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 117
COVID-19, adaptative immune response and metabolic-associated liver disease 115
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 113
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 112
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 111
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 109
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 97
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 94
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 31
Serum-free light chains as a dependable biomarker for stratifying patients with metabolic dysfunction-associated steatotic liver disease 29
Totale 7.487
Categoria #
all - tutte 31.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022309 0 0 0 0 30 16 11 62 20 16 65 89
2022/20231.131 177 145 74 168 67 118 71 89 119 17 63 23
2023/2024581 31 144 8 54 15 107 46 24 8 25 52 67
2024/20251.144 53 37 83 46 102 52 21 60 172 110 217 191
2025/20262.794 360 57 203 393 532 140 490 130 158 172 75 84
2026/20271.051 115 170 219 405 142 0 0 0 0 0 0 0
Totale 7.487